Database for the Assessment of Efficacy and Safety of BPH Treatment
KSSG-BPH-REG
1 other identifier
observational
500
1 country
1
Brief Summary
This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 7, 2017
CompletedFirst Submitted
Initial submission to the registry
April 29, 2018
CompletedFirst Posted
Study publicly available on registry
May 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
January 26, 2021
January 1, 2021
10.4 years
April 29, 2018
January 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Reduction of Lower Urinary Tract Symptoms
Change of total score of International Prostate Symptoms Score (IPSS; range 0 points (no symptoms) to 35 points (severe symptoms))
baseline to 1 year
Changes of free urinary flow rate
Measurement of urinary stream (mL/s) by urinary flow rate measurement
baseline to 1 year
Changes of post void residual urine
Measurement of post void residual urine (mL) by transabdominal ultrasound
baseline to 1 year
Secondary Outcomes (54)
Reduction of Lower Urinary Tract Symptoms
baseline to 6 weeks
Reduction of Lower Urinary Tract Symptoms
baseline to 12 weeks
Reduction of Lower Urinary Tract Symptoms
baseline to 6 months
Reduction of Lower Urinary Tract Symptoms
baseline to 2 years
Reduction of Lower Urinary Tract Symptoms
baseline to 5 years
- +49 more secondary outcomes
Study Arms (3)
PAE
Men with BPH - LUTS BPE who have opted for PAE and have consented to take part in the Register Study.
TURP
Men with BPH - LUTS BPE who have opted for TURP and have consented to take part in the Register Study.
Other
Men with BPH - LUTS BPE who have opted for other treatment options (e.g., holmium laser enucleation of the prostate, open prostatectomy, thulium laser vaporization, resection or enucleation, transurethral incision of the prostate) and have consented to take part in the Register Study.
Interventions
Other surgical procedures for BPH treatment including holmium laser enucleation of the prostate, open prostatectomy, thulium laser vaporization, resection or enucleation, transurethral incision of the prostate
Eligibility Criteria
All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG
You may qualify if:
- All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG
- Patient age ≥ 18 years
- Informed consent provided
You may not qualify if:
- Cognitive impairment not allowing Informed Consent or adequate data assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dominik Abtlead
Study Sites (1)
St. Gallen Cantonal Hospital
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr. med. Dominik Abt
Study Record Dates
First Submitted
April 29, 2018
First Posted
May 11, 2018
Study Start
July 7, 2017
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
January 26, 2021
Record last verified: 2021-01